Diagnos (ADK.V) announced today that it has signed a 3-year contract with Cielo Vista Eye Clinic in Mexico. According to the contract, Diagnos will supply its CARA platform to…
vision loss
Aequus Pharmaceuticals (AQS.V) and reVision Therapeutics today announced a collaboration on the development of a therapy for Stargardt disease. The agreement will provide the Company with the option to…
Diagnos (ADK.V), a leader in early detection announced today that it has signed a pilot in Spain with three franchisees from Opticalia Group. “The campaign begins with the request…
On July 22, 2021 Diagnos (ADK.V) announced the official opening of the initial clinics at the Magrabi Hospital in Saudi Arabia. DIAGNOS specialises in early detection of health problems…
Ocuphire Pharma (OCUP.Q), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for treatment of several eye disorders, announced today that its VEGA-1 Phase 2 clinical trial…
Diagnos (ADK.V) announced today that it has signed a two-month pilot with Hospital Oftalmologico Buena Vista Sinaloa (BVS), the largest ophthalmological hospital in Sinaloa state, Mexico. “Our focus is…
DIAGNOS specialises in early detection of health problems based on its FLAIRE artificial intelligence (AI) platform….